All In Biotech

Drug Trial Radar · NCT07196748

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

A Phase 3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol in Adults With an Open Label Study in Adolescents to Evaluate the Efficacy and Safety of Induction and Maintenance Therapy With Icotrokinra in Participants With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 896 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

896

Actual

Start

Oct 1, 2025

Primary completion

Jan 14, 2028

Study completion Jan 13, 2032

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Sep 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops tiny open ulcers).

Conditions

  • Colitis, Ulcerative

Interventions

  • IcotrokinraDrug

    Icotrokinra tablet will be administered orally.

  • PlaceboDrug

    Placebo tablet will be administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Double-blind (DB) Induction Study: Percentage of Adult Participants in Clinical Remission at Week I-12Time frame: At Week I-12
  2. DB Maintenance Study: Percentage of Adult Participants in Clinical Remission at Week M-40Time frame: At Week M-40
  3. Open-Label (OL) Maintenance Phase: Percentage of Adolescent Participants in Clinical Remission at Week M-40Time frame: At Week M-40

Locations

402 sites in 28 countries. Site status is shown where the registry gives one.

  • AZ Gastro Care

    Chandler, Arizona

  • Research Solutions of Arizona

    Litchfield Park, Arizona

  • Mayo Clinic

    Scottsdale, Arizona

  • Clinnova Research

    Anaheim, California

  • Southern California Research Center

    Coronado, California

  • Om Research LLC

    Lancaster, California

  • TLC Clinical Research Inc

    Los Angeles, California

  • GastroIntestinal Bioscience

    Los Angeles, California

  • Hoag Memorial Hospital

    Newport Beach, California

  • Om Research LLC 2

    Oxnard, California

  • Stanford Medicine Children's Health

    Palo Alto, California

  • Clinical Applications Laboratories, Inc

    San Diego, California

  • Medical Associates Research Group, Inc.

    San Diego, California

  • University of California San Francisco

    San Francisco, California

  • Peak Gastroenterology Associates

    Colorado Springs, Colorado

  • Nuvance Health Danbury Hospital

    Danbury, Connecticut

  • Connecticut Children's Medical Center

    Hartford, Connecticut

  • American Institute of Research

    Cutler Bay, Florida

  • Nature Coast Clinical Research

    Inverness, Florida

  • Florida Research Institute

    Lakewood Rch, Florida

  • GCP Clinical Research

    Tampa, Florida

  • Atlanta Gastroenterology Associates

    Atlanta, Georgia

  • Children's Center for Digestive Health Care

    Atlanta, Georgia

  • Gastroenterolgy Associates of Central GA

    Macon, Georgia

  • IU Health University Hospital

    Indianapolis, Indiana

  • Cotton O'Neil Digestive Health Center

    Topeka, Kansas

  • Tri-State Gastroenterology Assoc

    Crestview Hills, Kentucky

  • Delta Research Partners, LLC

    West Monroe, Louisiana

  • Chevy Chase Clinical Research

    Chevy Chase, Maryland

  • Woodholme Gastroenterology Associates

    Glen Burnie, Maryland

  • Westchester Putnam Gastroenterology

    Carmel, New York

  • Inflammatory Bowel Disease Center at NYU Langone

    New York, New York

  • Manhattan Clinical Research LLC

    New York, New York

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • Weill Cornell Medical College

    New York, New York

  • Lenox Hill Hospital

    New York, New York

  • New York Gastroenterology Associates

    New York, New York

  • University of North Carolina

    Chapel Hill, North Carolina

  • Atrium Health

    Charlotte, North Carolina

  • Digestive Disease Specialists Inc

    Oklahoma City, Oklahoma

Showing 40 of 402 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.